This further confirms the strong association between mammaglobin-1 expression and CA15-3 in BC patients’ samples (Figs. 4D,E) and highlights the possible use of mammaglobin-1 as an alternative marker for CA15-3 in the prediction of BM micrometastases in BC patients. This evidence concerns the gene SCGB2A2 and breast cancer.